RNA Expression of MMP12 Is Strongly Associated with Inflammatory Bowel Disease and Is Regulated by Metabolic Pathways in RAW 264.7 Macrophages

Laura Arosa,Miguel Camba-Gómez,Luis Francisco Lorenzo-Martín,Laura Clavaín,Miguel López,Javier Conde-Aranda
DOI: https://doi.org/10.3390/ijms25063167
IF: 5.6
2024-03-10
International Journal of Molecular Sciences
Abstract:Macrophage metalloelastase or matrix metalloproteinase-12 (MMP12) is a macrophage-specific proteolytic enzyme involved in the physiopathology of many inflammatory diseases, including inflammatory bowel disease. Although previously published data suggested that the modulation of MMP12 in macrophages could be a determinant for the development of intestinal inflammation, scarce information is available on the mechanisms underlying the regulation of MMP12 expression in those phagocytes. Therefore, in this study, we aimed to delineate the association of MMP12 with inflammatory bowel disease and the molecular events leading to the transcriptional control of this metalloproteinase. For that, we used publicly available transcriptional data. Also, we worked with the RAW 264.7 macrophage cell line for functional experiments. Our results showed a strong association of MMP12 expression with the severity of inflammatory bowel disease and the response to relevant biological therapies. In vitro assays revealed that the inhibition of mechanistic target of rapamycin complex 1 (mTORC1) and the stimulation of the AMP-activated protein kinase (AMPK) signaling pathway potentiated the expression of Mmp12. Additionally, AMPK and mTOR required a functional downstream glycolytic pathway to fully engage with Mmp12 expression. Finally, the pharmacological inhibition of MMP12 abolished the expression of the proinflammatory cytokine Interleukin-6 (Il6) in macrophages. Overall, our findings provide a better understanding of the mechanistic regulation of MMP12 in macrophages and its relationship with inflammation.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problem this paper attempts to address is the investigation of the association between matrix metalloproteinase-12 (MMP12) and inflammatory bowel disease (IBD), as well as its molecular regulatory mechanisms in macrophages. Specifically, the researchers aim to elucidate the following points by analyzing publicly available transcriptome data and conducting functional experiments using the RAW 264.7 macrophage cell line: 1. **Correlation between MMP12 and IBD**: The study confirms a strong association between MMP12 expression and the severity of IBD, as well as the response to biological therapy. 2. **Regulation of MMP12 by metabolic pathways**: It was found that the inhibition of mechanistic target of rapamycin complex 1 (mTORC1) and stimulation of the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway enhance MMP12 expression, and this effect is dependent on a functional glycolytic pathway. 3. **Impact of MMP12 on inflammatory mediators**: Pharmacological inhibition of MMP12 significantly reduces the expression of the pro-inflammatory cytokine interleukin-6 (IL-6) in macrophages. Overall, this paper provides an in-depth understanding of the mechanistic regulation of MMP12 in macrophages and its relationship with inflammation.